|
SLC25A5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.705870E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.980000E-03 |
| Normal-vs-Stage2 |
1.639800E-01 |
| Normal-vs-Stage3 |
9.118100E-03 |
| Normal-vs-Stage4 |
2.415900E-04 |
| Stage1-vs-Stage2 |
4.531900E-02 |
| Stage1-vs-Stage3 |
5.400800E-01 |
| Stage1-vs-Stage4 |
7.975700E-02 |
| Stage2-vs-Stage3 |
3.052400E-02 |
| Stage2-vs-Stage4 |
1.179530E-02 |
| Stage3-vs-Stage4 |
3.339400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.35049999999637E-05 |
| Normal-vs-AfricanAmerican |
4.17890000000698E-05 |
| Normal-vs-Asian |
2.293900E-02 |
| Caucasian-vs-AfricanAmerican |
1.986790E-01 |
| Caucasian-vs-Asian |
9.628000E-01 |
| AfricanAmerican-vs-Asian |
4.110600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.493600E-02 |
| Normal-vs-Female |
5.174200E-02 |
| Male-vs-Female |
5.391000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.604300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.16719999999571E-05 |
| Normal-vs-Age(61-80Yrs) |
4.530200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.169700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.651210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.733800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.161600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.722700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.457600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.906500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.005000E-01 |
| Classical-VS-Follicular |
2.361300E-04 |
| Classical-VS-Other |
5.410200E-01 |
| Classical-VS-Normal |
9.56279999630993E-08 |
| Tall-VS-Follicular |
1.562900E-03 |
| Tall-VS-Other |
3.547800E-01 |
| Tall-VS-Normal |
1.128180E-02 |
| Follicular-VS-Other |
1.106420E-02 |
| Follicular-VS-Normal |
3.580300E-02 |
| Other-VS-Normal |
1.039190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.136600E-01 |
| Normal-vs-N1 |
7.52690000327405E-08 |
| N0-vs-N1 |
1.034930E-04 |
|
|
